A trillion-dollar food industry sues to keep prevention at bay while governments spend billions subsidising the drugs that treat what bad diets do. Meanwhile, Ebola outruns a hollowed-out WHO, and its Director-General’s legacy hangs on whether he can get a grip. ‘If all else fails, sue’ Last week’s most telling global health story was not […] Continue reading ->
Nearly 90% of infants globally received at least one dose of a diphtheria, tetanus and pertussis (DTP) vaccine in 2025, while around one-third of girls globally received at least one dose of Human Papillomavirus (HPV) vaccine, which protects against cervical cancer. This is according to the annual World Health Organization (WHO)-UNICEF Estimates of National Immunization […] Continue reading ->
HPV vaccines have transformed cervical cancer prevention, but the next generation of vaccines must better reflect regional disease patterns, including the HPV35 genotype prevalent in Africa. The recent WHO Global Status Report on Cancer paints a sobering picture. Among the many challenges, human papillomavirus, or HPV, is one of the world’s most serious infectious causes of […] Continue reading ->
The election of the new executive director for the Global Fund to Fight AIDS, Tuberculosis and Malaria will move forward on schedule, according to a statement released by the organisation on Tuesday, 7 July. This announcement follows rumours that the nomination process might be restarted after the names of several US candidates who were reportedly […] Continue reading ->
“Those are people who are being killed socially.” That is how Dr. Marcus Lacerda, Director of the WHO-hosted Special Programme for Research and Training in Tropical Diseases (TDR), describes children whose futures are shaped by repeated bouts of vivax malaria. Lacerda, who joined TDR in March 2026, has spent more than 25 years studying […] Continue reading ->
The Global Diabetes Compact aims to improve diagnosis, care, and access to life-saving medications for those with diabetes. Already, countries in high-burden regions have improved along these key metrics. But as the number of people living with diabetes is projected to increase nearly 50% globally by 2050, much more needs to be accomplished. In a […] Continue reading ->
Three leading Geneva-based non-profit organisations involved in the research and development (R&D) of “effective, affordable, and life-saving medicines” are pooling resources to address the growing unmet needs of the world’s most vulnerable patients. The Drugs for Neglected Diseases initiative (DNDi), the Global Antibiotic Research and Development Partnership (GARDP), and Medicines for Malaria Venture (MMV) announced […] Continue reading ->
The World Health Organization’s estimate of the number of suspected, but as yet unconfirmed, cases of the deadly Ebola Bundibugyo virus has sharply declined from over 1000 a week ago to just 116 today, WHO on Wednesday. That doesn’t mean that the tide has yet turned on the outbreak. But WHO officials sounded notes of […] Continue reading ->
Afrigen Biologics, the South African facility that developed an mRNA vaccine from scratch during COVID-19, has become the first African facility to be certified to manufacture investigational biological products for Phase I and II clinical trials. The facility celebrated receiving its Good Manufacturing Practice (GMP) certification for its mRNA facility in Cape Town from the […] Continue reading ->
This week’s announcement of BioNTech factory closures in Germany marks an end to the country’s pandemic-era COVID-19 vaccine production boom. The Mainz-based pioneer announced that it will manufacture its final batches of the vaccine domestically later this year, transferring all future production to its American partner, Pfizer. This strategic retreat from Germany – which includes […] Continue reading ->